# Agnitio Inc – FDA Inspection, Nov 9, 2018

Source: https://www.keypedia.com/records/fda_inspections/agnitio-inc/2c56e945-ad0b-4c2a-bbd0-ff49e367246e
Source feed: FDA_Inspections

> FDA inspection 1071299 of Agnitio Inc, November 09, 2018. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1071299
- Company Name: Agnitio Inc
- Inspection Date: 2018-11-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Minneapolis District Office
- Citation Count: 6

## Related Documents

- FDA Inspection 1295362 - 2025-11-21
- [FDA Inspection 1146649 - 2021-06-04](https://www.keypedia.com/records/fda_inspections/agnitio-inc/d19d5009-9492-4a21-8033-cd779e5d70df)
- [FDA Inspection 1059372 - 2018-07-19](https://www.keypedia.com/records/fda_inspections/agnitio-inc/6afe22f8-1834-4baa-815d-6577357bb3f8)

## Related Officers

- [Investigator](https://www.keypedia.com/people/sandra-a-boyd/c469103a-0917-407a-b9d1-98273358dfeb)

Company: https://www.keypedia.com/companies/agnitio-inc/6bcd09b9-e002-45bf-805c-0e4474b1bdfb

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d